Cargando…
Development of a dynamic risk system for predicting the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer after thulium laser resection of bladder tumor or transurethral resection of bladder tumor followed by intravesical BCG instillation
BACKGROUND: The high recurrence rate of non-muscle-invasive bladder cancer (NMIBC) after tumor resection brings huge physical and financial burdens for patients. Several predictive models that predict the recurrence of patients with NMIBC have drawbacks in clinical practice. With the rapid developme...
Autores principales: | Sun, Jian-Xuan, An, Ye, Xu, Meng-Yao, Liu, Chen-Qian, Xu, Jin-Zhou, Xia, Qi-Dong, Wang, Shao-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354449/ https://www.ncbi.nlm.nih.gov/pubmed/37476386 http://dx.doi.org/10.3389/fonc.2023.1133161 |
Ejemplares similares
-
Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Liu, Zheng, et al.
Publicado: (2021) -
AB138. Experience on thulium laser treatment in transurethral resection of bladder tumor
por: Gan, Xiuguo, et al.
Publicado: (2016) -
Intravesical explosion during transurethral resection of bladder tumor: A case report
por: Xu, Chuan-Bing, et al.
Publicado: (2022) -
Thulium laser en bloc resection versus conventional transurethral resection of urinary bladder tumor: A comparative prospective study
por: Badawy, Atef, et al.
Publicado: (2023) -
Body composition as a predictor of oncological outcome in patients with non-muscle-invasive bladder cancer receiving intravesical instillation after transurethral resection of bladder tumor
por: Huang, Liang-Kang, et al.
Publicado: (2023)